3-氯-2,4(3H,5H)-呋喃二酮 、 硫脲 在
水 、 disodium;carbonate 作用下,
以
烯丙醇 为溶剂,
反应 16.0h,
以to afford 4.6 g of product as a white solid的产率得到allyl 2-amino-4-(hydroxymethyl)-1,3-thiazole-5-carboxylate
[EN] PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY<br/>[FR] DÉRIVÉS DU PYRROLE AYANT UNE ACTIVITÉ ANTIBACTÉRIENNE
申请人:ASTRAZENECA AB
公开号:WO2008020222A1
公开(公告)日:2008-02-21
[EN] Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described. [FR] La présente invention concerne des composés de formule (I) et leurs sels pharmaceutiquement acceptables. Des procédés destinés à leur préparation, des compositions pharmaceutiques les contenant, leur utilisation en tant que médicaments et leur utilisation dans le traitement d'infections bactériennes sont également décrits.
[EN] KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE
申请人:ALLERGAN INC
公开号:WO2010075197A1
公开(公告)日:2010-07-01
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.
WO2008/20222
申请人:——
公开号:——
公开(公告)日:——
PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY
申请人:Basarab Gregory
公开号:US20100286181A1
公开(公告)日:2010-11-11
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.